Raltegravir
Overview
Raltegravir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL254316).
API suppliers (7)
Suppliers of Raltegravir evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 5 of 7 suppliers.
4 of 7 hold a GMP certificate on record in the EU or UK registers
- MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- LUPIN MANUFACTURING SOLUTIONS LTD1 active DMF
- APICORE LLC (A WHOLLY OWNED SUB OF RK PHARMA INC)1 active DMF
- Hetero Drugs LimitedIndia1 active DMF GMP on record
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- Lupin LimitedIndia GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Raltegravir expires 30 Mar 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
- Canonical SMILES
- CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F
- InChIKey
- CZFFBEXEKNGXKS-UHFFFAOYSA-N
Do you supply Raltegravir? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.